Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus

X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the... Three forms of X–linked spastic paraplegia (SPG) have been defined. One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2). A rare X–linked dysmyelinating disorder of the central nervous system, Pelizaeus–Merzbacher disease (PMD), has also been mapped to Xq21–q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20. While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene. We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20,and segregates with the disease (Zmax=6.63, θ=0.00). It appears, therefore, that SPG2 and PMD are allelic disorders. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Genetics Springer Journals

X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus

Loading next page...
 
/lp/springer-journals/x-linked-spastic-paraplegia-and-pelizaeus-merzbacher-disease-are-DlMycUDRZ6

References (66)

Publisher
Springer Journals
Copyright
Copyright © 1994 by Nature Publishing Group
Subject
Biomedicine; Biomedicine, general; Human Genetics; Cancer Research; Agriculture; Gene Function; Animal Genetics and Genomics
ISSN
1061-4036
eISSN
1546-1718
DOI
10.1038/ng0394-257
Publisher site
See Article on Publisher Site

Abstract

Three forms of X–linked spastic paraplegia (SPG) have been defined. One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2). A rare X–linked dysmyelinating disorder of the central nervous system, Pelizaeus–Merzbacher disease (PMD), has also been mapped to Xq21–q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20. While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene. We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20,and segregates with the disease (Zmax=6.63, θ=0.00). It appears, therefore, that SPG2 and PMD are allelic disorders.

Journal

Nature GeneticsSpringer Journals

Published: Mar 1, 1994

There are no references for this article.